LFB develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields. Apriso will help LFB to improve operational workflows within a regulatory environment, supported by FlexNet's RFID-enabled tracking capabilities, according to Apriso.
"Part of LFB's selection process was based on two factors: Apriso's market momentum in the life sciences industry and Apriso's ability to support both discrete and process life sciences operations," said Rick Gallisa, industry director, life sciences at Apriso. "The regulated biopharmaceutical environment at LFB is very demanding in terms of quality and traceabilityboth inherent capabilities within Apriso's solution."
Apriso is a Long Beach, Calif.-based provider of adaptive software for global manufacturing operations management (MOM).
Interested in information related to this topic? Subscribe to our Information Technology eNewsletter.
